[Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines]

Enferm Infecc Microbiol Clin. 2012 Oct;30(8):508-9; author reply 511-2. doi: 10.1016/j.eimc.2012.06.002. Epub 2012 Jul 21.
[Article in Spanish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents / economics*
  • HIV Infections / economics*
  • Humans
  • National Health Programs / economics*
  • Practice Guidelines as Topic*

Substances

  • Anti-HIV Agents